Experiment: 5JDP

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	R1 relaxation rate	0.8 mM U- 2H, 15N_sample E73V mutant of the Voltage-dependent anion channel 1, 2 % [U-2H] LDAO, 20 mM [U-2H] TRIS	90% H2O/10% D2O	20 mM	6.8	1 atm	310	Bruker AVANCE 600
2	R2 relaxation rate	0.8 mM U- 2H, 15N_sample E73V mutant of the Voltage-dependent anion channel 1, 2 % [U-2H] LDAO, 20 mM [U-2H] TRIS	90% H2O/10% D2O	20 mM	6.8	1 atm	310	Bruker AVANCE 600
3	R1 relaxation rate	0.8 mM U- 2H, 15N_sample E73V mutant of the Voltage-dependent anion channel 1, 2 % [U-2H] LDAO, 20 mM [U-2H] TRIS	90% H2O/10% D2O	20 mM	6.8	1 atm	310	Bruker AVANCE 700
4	R2 relaxation rate	0.8 mM U- 2H, 15N_sample E73V mutant of the Voltage-dependent anion channel 1, 2 % [U-2H] LDAO, 20 mM [U-2H] TRIS	90% H2O/10% D2O	20 mM	6.8	1 atm	310	Bruker AVANCE 700
5	R1 relaxation rate	0.8 mM U- 2H, 15N_sample E73V mutant of the Voltage-dependent anion channel 1, 2 % [U-2H] LDAO, 20 mM [U-2H] TRIS	90% H2O/10% D2O	20 mM	6.8	1 atm	310	Bruker AVANCE 900
6	R2 relaxation rate	0.8 mM U- 2H, 15N_sample E73V mutant of the Voltage-dependent anion channel 1, 2 % [U-2H] LDAO, 20 mM [U-2H] TRIS	90% H2O/10% D2O	20 mM	6.8	1 atm	310	Bruker AVANCE 900
7	3D 1H-15N NOESY	0.8 mM U- 2H, 15N_sample E73V mutant of the Voltage-dependent anion channel 1, 2 % [U-2H] LDAO, 20 mM [U-2H] TRIS	90% H2O/10% D2O	20 mM	6.8	1 atm	310	Bruker AVANCE 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600
2	Bruker	AVANCE	700
3	Bruker	AVANCE	900
4	Bruker	AVANCE	800

NMR Ensemble Information
Conformer Selection Criteria
Conformers Calculated Total Number
Conformers Submitted Total Number	20

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	Xplor-NIH		Schwieters, Kuszewski, Tjandra and Clore
2	chemical shift assignment	CcpNmr Analysis		CCPN
3	structure calculation	Xplor-NIH		Schwieters, Kuszewski, Tjandra and Clore
4	peak picking	CcpNmr Analysis		CCPN

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.